In the News | Beasley Allen Law Firm | Helping those who need it most since 1979.

Beasley Allen in the News

...

Articles 471 to 480 of 684 .

Lawyers Huddle before Vioxx Blitz

| January 21, 2005

Most of the 250 lawyers listened intently as fellow attorney Barry Hill showed off an extensive collection of trinkets and product samples emblazoned with the logo of the now-withdrawn drug Vioxx.

Fourth Vioxx case set for Janurary 24, 2005

| January 10, 2005

The fourth Vioxx lawsuit against Merck & Co. will be held in a rural Texas court and a retrial of the federal case that ended in a hung jury will be held in February in New Orleans.

Merck witness has Chink in Armor

| January 8, 2005

During the past five months, Merck researcher Alise Reicin has stood toe-to-toe with some of the nation's best trial lawyers.

Dental group sues Blue Cross

| January 7, 2005

The Alabama Dental Association is suing Blue Cross and Blue Shield of Alabama, claiming the insurance company defrauded roughly 1,600 dentists out of more than $100 million in reimbursements.

Prescription for Travel

| January 1, 2005

Andy Birchfield, got a jump start on the Vioxx litigation, he began filing cases in 2001, three years before Merck & Co., Inc., pulled its prescription painkiller from the shelf.

Merck & Co.'s chief executive for 10 years, Gilmartin withdrew the painkiller Vioxx in the biggest prescription-drug recall ever, prompting at least 475 lawsuits against the No. 2 U.S. drugmaker by Vioxx users.

Keeping Celebrex on the market is Calculated Risk for Pfizer

| December 21, 2004

Pfizer Inc.s decision to stand behind Celebrex rather than withdraw its painkiller, as rival Merck & Co. did with Vioxx, puts the company on a risky legal path.

As safety issues hit Celebrex, Pfizer decides to hang Tough

| December 20, 2004

Pfizer is betting that the medical community and consumers will ultimately decide theres still a valid need for a Cox-2 inhibitor, the class of painkillers that includes Celebrex.

Who's who in the Vioxx Lawsuits

| December 19, 2004

When the pharmaceutical company Merck pulled painkiller Vioxx off the market after a study linked it to heart attacks and strokes, lawsuits against the drug maker were already under way across the country.